RB1 and non-small cell lung carcinoma: On multivariate analysis (Table 2), after adjusting for age, sex, stage, smoking status, receipt of chemotherapy, and other gene mutations, RB1 mutant status was still predictive of worse outcomes in NSCLC (HR = 3.07, 95% CI = 1.54‐6.14, P = 0.002).